All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR GROUP REVENUES

EBITDA (2024)

97,5 (19,1% of turnover)

EBIT (2024)

69,0 (13,5% of turnover)

NET RESULT (2024)

42,1 (8,3% of turnover)

Related Documents

Discover more

OUR GROUP FIGURES BY FOCUS AREA (%, 2024)

29,8 %

JOINT CARE

23,7 %

EYE CARE

15,7 %

SPECIALTY CARE

9 %

SKIN CARE

7 %

HEALTH & WELNESS CARE

1,8 %

REGENERATIVE CARE

13 %

OTHER

OUR FIGURES BY PRODUCT CATEGORY (2024)

42 %

PRESCRIPTION DRUGS

40 %

MEDICAL DEVICES

4 %

VACCINES

14 %

OTHER

OUR GROUP FIGURES BY GEOGRAPHICAL AREA (%, 2024)

51,8 %

ITALY

23,9 %

EUROPE

12,4 %

USA

4,9 %

MENA

7 %

RoW

OUR GROUP

GOVERNANCE

Find out more